| RS121909215 |
TGFBI
|
Health Risk |
Pathogenic |
Reis-Bucklers' corneal dystrophy, Reis-Bucklers' corneal dystrophy |
| RS121909216 |
TGFBI
|
Health Risk |
Pathogenic |
Epithelial basement membrane dystrophy, Epithelial basement membrane dystrophy |
| RS121909217 |
TGFBI
|
Health Risk |
Conflicting classifications of pathogenicity |
Epithelial basement membrane dystrophy, Corneal dystrophy |
| RS121909218 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS121909219 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS121909220 |
PTEN
|
Health Risk |
Pathogenic |
Lhermitte-Duclos disease, PTEN hamartoma tumor syndrome |
| RS121909221 |
PTEN
|
Health Risk |
Pathogenic |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS121909222 |
PTEN
|
Health Risk |
Pathogenic |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS121909223 |
PTEN
|
Health Risk |
Likely pathogenic |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS121909224 |
PTEN
|
Health Risk |
Pathogenic |
Macrocephaly-autism syndrome, Cowden syndrome 1 |
| RS121909225 |
PTEN
|
Health Risk |
Likely pathogenic |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS121909226 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS121909227 |
PTEN
|
Health Risk |
Pathogenic |
Cowden syndrome 1, Macrocephaly-autism syndrome |
| RS121909228 |
PTEN
|
Health Risk |
Pathogenic |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS121909229 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cowden syndrome 1, Hereditary cancer-predisposing syndrome |
| RS121909230 |
PTEN
|
Health Risk |
Pathogenic |
Lhermitte-Duclos disease, Hereditary cancer-predisposing syndrome |
| RS121909231 |
PTEN
|
Health Risk |
Pathogenic |
Proteus-like syndrome, Cowden syndrome 1 |
| RS121909232 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma, Cowden syndrome 1 |
| RS121909236 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Vater association with macrocephaly and ventriculomegaly, PTEN hamartoma tumor syndrome |
| RS121909237 |
PTEN
|
Health Risk |
Likely pathogenic |
Squamous cell carcinoma of the head and neck, Cowden syndrome 1 |
| RS121909238 |
PTEN
|
Health Risk |
Likely pathogenic |
Macrocephaly-autism syndrome, PTEN hamartoma tumor syndrome |
| RS121909239 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
Macrocephaly-autism syndrome, PTEN hamartoma tumor syndrome |
| RS121909240 |
PTEN
|
Health Risk |
Likely pathogenic |
Macrocephaly-autism syndrome, PTEN hamartoma tumor syndrome |
| RS121909241 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS121909242 |
PPARG
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS121909243 |
PPARG
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS121909244 |
PPARG
|
Health Risk |
Pathogenic/Likely pathogenic |
PPARG-related familial partial lipodystrophy, Lipodystrophy |
| RS121909245 |
PPARG
|
Health Risk |
Pathogenic |
PPARG-related familial partial lipodystrophy, PPARG-related familial partial lipodystrophy |
| RS121909246 |
PPARG
|
Health Risk |
Pathogenic |
PPARG-related familial partial lipodystrophy, PPARG-related familial partial lipodystrophy |
| RS121909247 |
IGFALS
|
Health Risk |
Pathogenic |
Short stature due to primary acid-labile subunit deficiency, Short stature due to primary acid-labile subunit deficiency |
| RS121909248 |
PITX2
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 4, Anterior segment dysgenesis |
| RS121909249 |
PITX2
|
Health Risk |
Likely pathogenic |
Axenfeld-Rieger syndrome type 1, Axenfeld-Rieger syndrome type 1 |
| RS121909250 |
ING1
|
Health Risk |
Pathogenic |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS121909251 |
ING1
|
Health Risk |
Pathogenic |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS121909252 |
ING1
|
Health Risk |
Pathogenic |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS121909253 |
LMAN1
|
Health Risk |
Pathogenic |
Factor V and factor VIII, combined deficiency of |
| RS121909254 |
RAPSN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS121909255 |
RAPSN
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS121909256 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 2, Fetal akinesia deformation sequence 2 |
| RS121909258 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia |
| RS121909259 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Neonatal severe primary hyperparathyroidism |
| RS121909260 |
CASR
|
Health Risk |
Likely pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS121909261 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Autosomal dominant hypocalcemia 1 |
| RS121909262 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS121909263 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Epilepsy |
| RS121909264 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia |
| RS121909265 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS121909266 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Autosomal dominant hypocalcemia 1 |
| RS121909268 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS121909272 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Cerebral creatine deficiency syndrome |
| RS121909273 |
BIN1
|
Health Risk |
Pathogenic |
Myopathy, centronuclear |
| RS121909274 |
BIN1
|
Health Risk |
Pathogenic |
Myopathy, centronuclear |
| RS121909275 |
BIN1
|
Health Risk |
Likely pathogenic |
Myopathy, centronuclear |
| RS121909281 |
CAV3
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 9, Cardiovascular phenotype |
| RS121909283 |
NODAL
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotaxy, visceral |
| RS121909284 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS121909285 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS121909286 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS121909287 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS121909288 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS121909289 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Cardiovascular phenotype |
| RS121909291 |
MOGS
|
Health Risk |
Pathogenic |
MOGS-congenital disorder of glycosylation, MOGS-congenital disorder of glycosylation |
| RS121909292 |
MOGS
|
Health Risk |
Pathogenic |
MOGS-congenital disorder of glycosylation, MOGS-congenital disorder of glycosylation |
| RS121909293 |
CTRC
|
Health Risk |
Conflicting classifications of pathogenicity; association |
Pancreatitis, chronic |
| RS121909294 |
CTRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancreatitis, chronic |
| RS121909295 |
SGCD
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L |
| RS121909296 |
SGCD
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F |
| RS121909297 |
SGCD
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L |
| RS121909299 |
OXCT1
|
Health Risk |
Pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS121909300 |
OXCT1
|
Health Risk |
Pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS121909301 |
OXCT1
|
Health Risk |
Pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS121909302 |
OXCT1
|
Health Risk |
Pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS121909304 |
ABCC9
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS121909305 |
MYO1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 48, MYO1A-related disorder |
| RS121909307 |
GSS
|
Health Risk |
Pathogenic |
Inherited glutathione synthetase deficiency, Inborn genetic diseases |
| RS121909308 |
GSS
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency without 5-oxoprolinuria |
| RS121909309 |
GSS
|
Health Risk |
Pathogenic/Likely pathogenic |
Inherited glutathione synthetase deficiency, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS121909323 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS121909324 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Inborn genetic diseases |
| RS121909326 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Migraine, familial hemiplegic |
| RS121909329 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1, Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 |
| RS121909330 |
VCP
|
Health Risk |
Pathogenic |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1, Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 |
| RS121909331 |
VCP
|
Health Risk |
Pathogenic |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 |
| RS121909332 |
VCP
|
Health Risk |
Likely pathogenic |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS121909334 |
VCP
|
Health Risk |
Pathogenic/Likely pathogenic |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1, Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 |
| RS121909335 |
VCP
|
Health Risk |
Pathogenic |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1, Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 |
| RS121909336 |
FOXF1
|
Health Risk |
Pathogenic |
Alveolar capillary dysplasia with pulmonary venous misalignment, Alveolar capillary dysplasia with pulmonary venous misalignment |
| RS121909337 |
FOXF1
|
Health Risk |
Pathogenic |
Alveolar capillary dysplasia with pulmonary venous misalignment, Alveolar capillary dysplasia with pulmonary venous misalignment |
| RS121909338 |
FOXC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS121909339 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS121909342 |
DCTN1
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS121909343 |
DCTN1
|
Health Risk |
Uncertain significance; risk factor |
Amyotrophic lateral sclerosis, susceptibility to |
| RS121909344 |
DCTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis, susceptibility to |
| RS121909346 |
CSTB
|
Health Risk |
Pathogenic |
Unverricht-Lundborg syndrome, Unverricht-Lundborg syndrome |
| RS121909347 |
GDF5
|
Health Risk |
Pathogenic |
Multiple synostoses syndrome 2, Multiple synostoses syndrome 2 |
| RS121909348 |
GDF5
|
Health Risk |
Pathogenic |
Brachydactyly type C, Brachydactyly type C |
| RS121909349 |
GDF5
|
Health Risk |
Pathogenic |
Symphalangism, proximal |
| RS121909350 |
GDF5
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 2B, Acromesomelic dysplasia 2B |
| RS121909351 |
GDF5
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 2B, Acromesomelic dysplasia 2B |
| RS121909352 |
GDF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Klippel-Feil syndrome 1, autosomal dominant |